Giovanni Del Poeta - Concepedia

Author

Giovanni Del Poeta

Also Known As

Del Poeta, G., G D Poeta, G Del Poeta, G Del-Poeta, G Poeta, G del Poeta, G. DEL POETA, G. Del Poeta, G. Poeta, G. del Poeta

434

Publications

11K

Citations

H-Index

108

Concepts

All Affiliations

St. Eugenio Hospital University of Rome Tor Vergata Centro di Riferimento Oncologico Istituti di Ricovero e Cura a Carattere Scientifico Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

About

Giovanni Del Poeta is an author at St. Eugenio Hospital specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	53	2.3K
2	Health Sciences	13	15	615
3	Engineering	2	2	99
4	Education	1	1	26
5	Allergy	1	1	21

Giovanni Del Poeta

136

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia Davide Rossi, Silvia Rasi, Valeria Spina, Blood	2012	454
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab Roberto Stasi, Nichola Cooper, Giovanni Del Poeta, Blood	2008	402
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) Giovanni Del Poeta, Adriano Venditti, Maria Ilaria Del Principe, Blood	2003	332
Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura Roberto Stasi, Giovanni Del Poeta, Elisa Stipa, Blood	2007	294
Clinical significance of CD38 expression in chronic lymphocytic leukemia Giovanni Del Poeta, Luca Maurillo, Adriano Venditti, Blood	2001	278
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Leukemia	2020	271
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia Valter Gattei, Pietro Bulian, Maria Ilaria Del Principe, Blood	2007	247
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia Adriano Venditti, Francesco Buccisano, Giovanni Del Poeta, Blood	2000	242
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab Roberto Stasi, Elisa Stipa, Giovanni Del Poeta, Lara D. Veeken	2006	219
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia Adriano Venditti, Francesco Buccisano, Giovanni Del Poeta, Blood	2000	217

Page 1